TherapeuticsMD to Host TX-004HR Regulatory Update Conference Call

8/5/2017 8:00

Conference Call TherapeuticsMD Inc

TherapeuticsMD Inc Conference call or earnings call will be held on May 8, 2017 During the earnings conference call's session TherapeuticsMD Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact TherapeuticsMD Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a women's health care company focused on creating and commercializing products targeted exclusively for women. Currently, we are focused on conducting the clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. The current drug candidates used in our clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. We are developing these hormone therapy drug candidates, which contain estradiol and progesterone alone or in combination, with the aim of demonstrating clinical efficacy at lower doses, thereby enabling an enhanced side effect profile compared with competing products. Our drug candidates are created using our SYMBODATM hormone technology, which enables the administration of hormones with high bioavailability alone or in combination.    
Read more Conference Call

TherapeuticsMD Inc (TXMD)

6800 Broken Sound Parkway NW, Boca Raton Florida 33487, United States